Advanced Center for Chronic Diseases Division de Enfermedades Cardiovasculares Facultad de Medicina Pontificia Universidad Católica de Chile Santiago Chile

Advisor Executive Committee World Hypertension League Hong Kong China

Advisor Food Nutrition and Physical Activity in Schools Pan American Health Organization Washington DC MD USA

Advisor to the Academic Vice Chancellor Maimonides University Buenos Aires Argentina

Aristotle University of Thessaloniki Thessaloniki Greece

Arterial Hypertension and Metabolic Unit University Hospital Fundacion Favaloro Medical Sciences Faculty University Dr RG Favaloro Buenos Aires Argentina

Associate Professor in Cardiology Department of Clinical Sciences Danderyd University Hospital Karolinska Institutet Stockholm Sweden

Board member Director Eastern European Regional Office World Hypertension League Hong Kong China

Board member Director World Hypertension League Hong Kong China

Board member Hellenic Society of Hypertension Athens Greece

Board Member World Hypertension League Hong Kong China

Bulgarian League of Hypertension President of Bulgarian Society of Cardiovascular Imaging Sofia Bulgaria

Center for Health Evaluation and Outcomes Sciences University of British Columbia Vancouver BC Canada

Chair Action on Salt London UK

Chair Action on Sugar London UK

Chair Blood Pressure UK London UK

Chair International Society of Hypertension Membership Committee International Society of Hypertension Colchester UK

Chair International Society of Hypertension Regional Advisory Group Americas Colchester Colchester UK

Chair of International Society of Hypertension Regional Advisory Group South and Central Asia Colchester UK

Chair World Action on Salt Sugar and Health London UK

Chairman of the Board German Society of Hypertension Heidelberg Germany

Chairman Slovak League against Hypertension Bratislava Slovakia

Charité Universitätsmedizin Berlin Institute of Clinical Pharmacology and Toxicology Berlin Germany

Chief Executive Officer and Co Founder Onom Foundation Onom Foundation Ulaanbaatar Mongolia

Chief Executive Officer Canadian Cardiovascular Society Ottawa ON Canada

Chief Program Officer Hypertension and Nutrition Core Group of India Association for Parenteral and Enteral Nutrition Maharashtra India

Clinic for Internal disease Intermedica Cardiology Department Hypertensive Centre Singidunum University School of Medicine Belgrade Serbia

Co Chair Global Policy Committee member of the Executive Committee World Stroke Organization Geneva Switzerland

Co Director Primary Aldosteronism Foundation Phoenix AZ USA

Coordinator Portuguese Society of Paediatric Working Group on Blood Pressure in Children and Adolescents Lisbon Portugal

Costa Rican Institute of Research and Teaching in Nutrition and Health Tres Rios Costa Rica

Dean Faculty of Clinical Sciences Director Center for Genomic and Precision Medicine College of Medicine University of Ibadan Ibadan Nigeria

Department of Anatomy and Physiology University of Melbourne Parkville VIC Australia

Department of Cardiology School of Medicine Mongolian National University of Medical Sciences Ulaanbaatar Mongolia

Department of Cardiovascular Sciences University of Leicester Leicester UK

Department of Family Medicine Semmelweis University Budapest Hungary

Department of Hypertension National Institute of Cardiology Warsaw Poland

Department of Internal Medicine Emory University Atlanta Georgia

Department of Medical Sciences School of Medical and Live Sciences Sunway University Bandar Sunway Selangor Malaysia

Department of Medicine and Surgery University of Milano Bicocca and IRCCS Istituto Auxologico Italiano Milan Italy

Department of Medicine University of Calgary Calgary AB Canada

Department of Medicine University of Ilorin Ilorin Nigeria

Department of Medicine University of the Philippines College of Medicine and St Luke's Medical Center Quezon City Philippines

Department of Nutritional Sciences Temerty Faculty of Medicine University of Toronto Toronto ON Canada

Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute Boston University School of Medicine Boston MA USA

Department of Preventive and Social Medicine University of Otago Dunedin New Zealand

Department of Preventive Cardiology National Cerebral and Cardiovascular Center Osaka Japan

Director Coalición Latinoamérica Saludable McKinney TX USA

Director of IAPEN Maharashtra India

Director of National Institute for Stroke and Applied Neurosciences Auckland University of Technology Auckland New Zealand

Director Policy and Advocacy Heart and Stroke Foundation of Canada Ottawa ON Canada

Director WHO Collaborating Centre on Nutrition Policy for Chronic Disease Prevention Toronto ON Canada

Division of Cardiology The Catholic University of Korea Seoul South Korea

Division of Cardiovascular Sciences Faculty of Medicine Biology and Health University of Manchester Manchester UK

Division of Translational Neurosciences and Population Studies Department of Neurology Medical University of South Carolina Charleston SC USA

Dobney Hypertension Centre Medical School Royal Perth Hospital Unit Royal Perth Hospital Research Foundation The University of Western Australia Perth WA Australia

Executive Director InterAmerican Heart Foundation Dallas TX USA

Faculty of Health Sciences Ontario Tech University Oshawa ON Canada

Faculty of Medicine and Surgery University of Santo Tomas Manila Philippines

Founder and Secretary Dr Bindu Menon Foundation Nellore India

Founding Chair Steering Committee African Stroke Organization Ibadan Nigeria

Full Professor of Internal Medicine and Director of the Faculty of Medical Sciences State University of Rio de Janeiro Rio de Janeiro Brazil

General Director National Institute of Food and Nutrition Service Seoul South Korea

Head Continuous Professional Development Saudi Hypertension Management Society Riyadh Saudi Arabia

Health Innovation and Transformation Centre Federation University Australia Ballarat VIC Australia

Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Immediate Past President Malaysian Society of Hypertension Selangor Malaysia

Immediate Past President Philippine Society of Hypertension Pasig City Philippines

Institute for Advanced Medical Research and Training and Center for Genomic and Precision Medicine College of Medicine University of Ibadan Ibadan Nigeria

International Council of Cardiovascular Prevention and Rehabilitation Markham ON Canada

International Society of Hypertension Education Lead Colchester UK

Italian Society of Arterial Hypertension Milan Italy

Karachi Institute of Heart Diseases Karachi Pakistan

Lead Co Chair Lancet Commission on Stroke London UK

Manchester Heart Centre and Manchester Academic Health Science Centre Manchester University NHS Foundation Trust Manchester UK

Member Research and Education Committee International Society of Hypertension Colchester UK

National and Kapodistrian University of Athens Athens Greece

NCD Global Program Leader PATH Seattle WA USA

Nutritionist Brazilian Society of Hypertension Sao Paulo Brazil

Officer at Large International Society of Hypertension Chair International Society of Hypertension Research and Education Committee International Society of Hypertension Colchester UK

Past President Argentine Society of Arterial Hypertension Buenos Aires Argentina

Past President Brazilian Society of Hypertension Sao Paulo Brazil

Past President British and Irish Hypertension Society Edinburgh UK

Past President of the Central American and Caribbean Association of Nephrology and Hypertension Santa Domingo Dominican Republic

Past President Serbian Society of Hypertension Nis Serbia

Past President Treasurer High Blood Pressure Research Council of Australia Tuggerah NSW Australia

Past President World Hypertension League Hong Kong China

President Canadian Society of Nephrology Montreal QC Canada

President Cardiology Branch Chinese Medical Doctors Association Beijing China

President Chilean Society of Hypertension Santiago Chile

President Chinese Hypertension League Beijing China

President Czech Society of Hypertension Prague Czech Republic

President Elect Iranian Heart Federation Tehran Iran

President Elect World Hypertension League Hong Kong China

President European Society of Hypertension Zug Switzerland

President High Blood Pressure Research Council of Australia Tuggerah NSW Australia

President Hong Kong College of Cardiology Hong Kong China

President Hypertension Canada Toronto ON Canada

President Indian Society of Hypertension Lucknow India

President International Society of Hypertension Colchester UK

President International Society of Nephrology Brussels Belgium

President Japanese Society of Hypertension Tokyo Japan

President Korean Society of Community Nutrition Seoul South Korea

President Korean Society of Hypertension Seoul South Korea

President Latin American Society of Hypertension Buenos Aires Argentina

President Latin American Society of Nephrology and Hypertension Innova Panama

President Lebanese Hypertension League Beirut Lebanon

President Malaysian Society for World Action on Salt Sugar and Health Selangor Malaysia

President Mongolian Society of Hypertension Ulaanbaatar Mongolia

President Philippine Society of Hypertension Pasig City Philippines

President Polish Society of Hypertension Gdansk Poland

President Portuguese Society of Hypertension Lisbon Portugal

President Swedish Society for Hypertension Stroke and Vascular Medicine Stockholm Sweden

President World Hypertension League Hong Kong China

Professor of Medicine and Cardiology Director of Isfahan Cardiovascular Research Center Isfahan Iran

Professor of Medicine Division of Cardiovascular Disease State University of New York Downstate Medical Center New York NY USA

Professor of Pathology Microbiology and Immunology Professor of Medicine John L Shapiro Chair of Pathology Professor of Pediatrics Vanderbilt University Nashville TN USA

Resolve to Save Lives an Initiative of Vital Strategies New York NY USA

Sanatorio Allende Córdoba Argentina

School of Medicine Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

Secretary General and Founder Trustee Pakistan Hypertension League Karachi Pakistan

Secretary General Hungarian Society of Hypertension Budapest Hungary

Secretary General Nigerian Hypertension Society Ibadan Nigeria

Secretary General World Hypertension League Hong Kong China

Secretary International Society of Hypertension Colchester UK

Seoul National University Seoul Seoul South Korea

Singapore Heart Foundation Singapore Singapore

Sofia University Faculty of Medicine Center of Cardiovascular diseases Sofia Bulgaria

Special Advisor to the board and Past president World Hypertension League Hong Kong China

The George Institute for Global Health Department of Epidemiology and Biostatistics School of Public Health Imperial College London St Mary's Campus Norfolk Place Paddington London UK

The George Institute for Global Health University of New South Wales Sydney NSW Australia

The Shanghai Institute of Hypertension Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

Treasurer Hellenic Society of Hypertension Athens Greece

Treasurer International Society of Hypertension Colchester UK

Tulane University School of Public Health and Tropical Medicine New Orleans LA USA

University College London NIHR University College London Hospitals Biomedical Research Centre London UK

University of Warwick WHO Collaborating Centre for Nutrition Warwick Medical School Coventry UK

Vice President World Hypertension League Hong Kong China

WHO Collaborating Center Cardiovascular Research Institute Isfahan University of Medical Sciences Isfahan Iran

WHO Collaborating Centre on Population Salt Reduction Sydney NSW Australia

Wolfson Institute of Population Health Barts and The London School of Medicine and Dentistry Queen Mary University of London London UK

World Stroke Organization Geneva Geneva Switzerland

Yale University New Haven CT USA

See more in PubMed

Campbell NRC, Schutte AE, Varghese CV, Ordunez P, Zhang X-H, Khan T, et al. São Paulo call to action for the prevention and control of high blood pressure: 2020. J Clin Hypertens. 2019;21:1744–52. doi: 10.1111/jch.13741. PubMed DOI PMC

Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317:165–82. doi: 10.1001/jama.2016.19043. PubMed DOI

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010. PubMed DOI PMC

Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285–92. doi: 10.1161/HYPERTENSIONAHA.119.14240. PubMed DOI PMC

Institute of Medicine (US) Committee on Public Health Priorities to Reduce and Control Hypertension. A population-based policy and systems change approach to prevent and control hypertension. Washington, DC, USA: National Academies Press; 2010. Report No.: 0-309-14810-3. PubMed

Joffres M, Campbell NR, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol. 2007;23:437–43. doi: 10.1016/S0828-282X(07)70780-8. PubMed DOI PMC

Fan W-G, Xie F, Wan Y-R, Campbell NRC, Su H. The impact of changes in population blood pressure on hypertension prevalence and control in China. J Clin Hypertens. 2020;22:150–6. doi: 10.1111/jch.13820. PubMed DOI PMC

World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization; 2021. PubMed

Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, et al. INTERSALT revisited: further analyses of 24 h sodium excretion and blood pressure within and across populations. BMJ. 1996;312:1249–53.. doi: 10.1136/bmj.312.7041.1249. PubMed DOI PMC

Van Vliet BN, Montani JP. The time course of salt-induced hypertension, and why it matters. Int J Obes(Lond) 2008;32:S35–47. doi: 10.1038/ijo.2008.205. PubMed DOI

Institute for Health Metrics and Evaluation, Global Burden of Disease Study. [updated 2021; cited June 8 2021]. “Global Burden of Disease Study.”]. Available from: http://vizhub.healthdata.org/gbd-compare/

Campbell NR, Correa-Rotter R, Cappuccio FP, Webster J, Lackland DT, Neal B, et al. Proposed nomenclature for salt intake and for reductions in dietary salt. J Clin Hypertens. 2015;17:247–51. doi: 10.1111/jch.12442. PubMed DOI PMC

Mancilha-Carvalho Jde J, Souza e Silva NA. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003;80:289–300. PubMed

Gleibermann L. Blood pressure and dietary salt in human populations. Ecol Food Nutr. 1973;2:143–56. doi: 10.1080/03670244.1973.9990329. DOI

Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014. doi: 10.1038/nrdp.2018.14. PubMed DOI PMC

He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease: JACC State-of-the-art review. J Am Coll Cardiol. 2020;75:6632–47. doi: 10.1016/j.jacc.2019.11.055. PubMed DOI

Filippini T, Malavolti M, Whelton PK, Naska A, Orsini N, Vinceti M. Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies. Circulation. 2021;143:1542–67. doi: 10.1161/CIRCULATIONAHA.120.050371. PubMed DOI PMC

Huang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NRC, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ. 2020;368:m315. doi: 10.1136/bmj.m315. PubMed DOI PMC

National, Academies of Sciences, Engineering, and, Medicine, 2019. Dietary reference intakes for sodium and potassium. Washington (DC): National Academies Press (US). PubMed

Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326. doi: 10.1136/bmj.f1326. PubMed DOI PMC

Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129:981–9. doi: 10.1161/CIRCULATIONAHA.113.006032. PubMed DOI PMC

Ma Y, He FJ, Sun Q, Yuan C, Kieneker LM, Curhan GC, et al. 24-hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med. 2021 doi: 10.1056/NEJMoa2109794.. PubMed DOI PMC

D’Elia L, Galletti F, Strazzullo P. Dietary salt intake and risk of gastric cancer. Cancer Treat Res. 2014;159:83–95. doi: 10.1007/978-3-642-38007-5_6. PubMed DOI

D’Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31:489–98. doi: 10.1016/j.clnu.2012.01.003. PubMed DOI

Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol. 2000;13:169–77. PubMed

Teucher B, Dainty JR, Spinks CA, Majsak-Newman G, Berry DJ, Hoogewerff JA, et al. Sodium and bone health: impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women. J Bone Miner Res. 2008;23:1477–85. doi: 10.1359/jbmr.080408. PubMed DOI

Bolhuis DP, Costanzo A, Newman LP, Keast RS. Salt promotes passive overconsumption of dietary fat in humans. J Nutr. 2016;146:838–45. doi: 10.3945/jn.115.226365. PubMed DOI

Moosavian SP, Haghighatdoost F, Surkan PJ, Azadbakht L. Salt and obesity: a systematic review and meta-analysis of observational studies. Int J Food Sci Nutr. 2017;68:265–77.. doi: 10.1080/09637486.2016.1239700. PubMed DOI

Hussain K, Murdin L, Schilder AG. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2018;12:Cd012173. PubMed PMC

Luxford E, Berliner KI, Lee J, Luxford WM. Dietary modification as adjunct treatment in Ménière’s disease: patient willingness and ability to comply. Otol Neurotol. 2013;34:1438–43. doi: 10.1097/MAO.0b013e3182942261. PubMed DOI

Amer M, Woodward M, Appel LJ. Effects of dietary sodium and the DASH diet on the occurrence of headaches: results from randomised multicentre DASH-Sodium clinical trial. BMJ Open. 2014;4:e006671. doi: 10.1136/bmjopen-2014-006671. PubMed DOI PMC

Evans RDR, Antonelou M, Henderson S, Walsh SB, Salama AD. Emerging evidence of an effect of salt on innate and adaptive immunity. Nephrol Dial Transplant. 2019;34:2007–14.. doi: 10.1093/ndt/gfy362. PubMed DOI

Faraco G, Brea D, Garcia-Bonilla L, Wang G, Racchumi G, Chang H, et al. Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response. Nat Neurosci. 2018;21:240–9. doi: 10.1038/s41593-017-0059-z. PubMed DOI PMC

Imaizumi Y, Eguchi K, Murakami T, Arakawa K, Tsuchihashi T, Kario K. High salt intake is independently associated with hypertensive target organ damage. J Clin Hypertens. 2016;18:315–21. doi: 10.1111/jch.12668. PubMed DOI PMC

Balan Y, Packirisamy RM, Mohanraj PS. High dietary salt intake activates inflammatory cascades via Th17 immune cells: impact on health and diseases. Arch Med Sci. 2020;18. 10.5114/aoms.2020.96344. PubMed PMC

Cappuccio FP, Beer M, Strazzullo P, on behalf of the European Salt Action Network. Population dietary salt reduction and the risk of cardiovascular disease. A scientific statement from the European Salt Action Network. Nutr Metab Cardiovasc Dis. 2018;29:107–14. doi: 10.1016/j.numecd.2018.11.010. PubMed DOI

EFSA Panel on Nutrition Novel Foods and Food Allergens. Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst K-I, Kearney J, et al. Dietary reference values for sodium. EFSA Journal. 2019;17:e05778. PubMed PMC

World Health Organization. WHO Guideline: Sodium intake for adults and children. Geneva, Switzerland: WHO Press; 2012. Report No.: 978 92 4 150483 6.

National Health and Medical Research Council, Australian Government Department of Health and Ageing, New Zealand Ministry of Health. Nutrient reference values for Australia and New Zealand including recommended dietary intakes. Australia; 2006. updated September 2017. Report No.: 1864962437.

Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334–57. doi: 10.1161/HYPERTENSIONAHA.120.15026. PubMed DOI

Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension-A report of the Revision Committee of Chinese Guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16:182–241. PubMed PMC

Cappuccio FP, Sever PS. The importance of a valid assessment of salt intake in individuals and populations. A scientific statement of the British and Irish Hypertension Society. J Hum Hypertens. 2019;33:345–8. doi: 10.1038/s41371-019-0203-1. PubMed DOI PMC

Aydoğdu S, Güler K, Bayram F, Altun B, Derici Ü, Abacı A, et al. [2019 Turkish hypertension consensus report] Turk Kardiyol Dern Ars. 2019;47:535–46. PubMed

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. doi: 10.1093/eurheartj/ehy339. PubMed DOI

Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;71:e13–e115. PubMed

Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019) Hypertens Res. 2019;42:1235–481.. doi: 10.1038/s41440-019-0284-9. PubMed DOI

Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Brazilian guidelines of hypertension - 2020. Arq Bras Cardiol. 2021;116:516–658. doi: 10.36660/abc.20201238. PubMed DOI PMC

Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ. 2013;3:e003733. PubMed PMC

Thout SR, Santos JA, McKenzie B, Trieu K, Johnson C, McLean R, et al. The Science of Salt: updating the evidence on global estimates of salt intake. J Clin Hypertens. 2019;21:710–21. doi: 10.1111/jch.13546. PubMed DOI PMC

Huang L, Crino M, Wu JH, Woodward M, Barzi F, Land MA, et al. Mean population salt intake estimated from 24-h urine samples and spot urine samples: a systematic review and meta-analysis. IntJ Epidemiol. 2016;45:239–50. doi: 10.1093/ije/dyv313. PubMed DOI

Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med. 1985;312:283–9. doi: 10.1056/NEJM198501313120505. PubMed DOI

Bhat S, Marklund M, Henry ME, Appel LJ, Croft KD, Neal B, et al. A systematic review of the sources of dietary salt around the world. Adv Nutr. 2020;11:677–86. doi: 10.1093/advances/nmz134. PubMed DOI PMC

Anderson CA, Appel LJ, Okuda N, Brown IJ, Chan Q, Zhao L, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010;110:736–45. doi: 10.1016/j.jada.2010.02.007. PubMed DOI PMC

Appel LJ, Foti K. Sources of dietary sodium. Circulation. 2017;135:1784–7. doi: 10.1161/CIRCULATIONAHA.117.027933. PubMed DOI PMC

Blanco-Metzler A, Moreira Claro R, Heredia-Blonval K, Caravaca Rodríguez I, Montero-Campos MDlA, Legetic B, et al. Baseline and estimated trends of sodium availability and food sources in the Costa Rican population during 2004–2005 and 2012–2013. Nutrients. 2017;9:1020. doi: 10.3390/nu9091020.. PubMed DOI PMC

World Health Organization. Global status report on noncommunicable disease 2014. Geneva, Switzerland: World Health Organization; 2014. Report No.: 978 92 4 156485 4.

World Health Organization. The updated Appendix 3 of the WHO Global NCD Action Plan 2013-2020. Best Buys. Geneva: World Health Organization; 2017.

Wang G, Labarthe D. The cost-effectiveness of interventions designed to reduce sodium intake. J Hypertens. 2011;29:1693–9. doi: 10.1097/HJH.0b013e328349ba18. PubMed DOI PMC

Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044–53. doi: 10.1016/S0140-6736(07)61698-5. PubMed DOI

Kontis V, Cobb LK, Mathers CD, Frieden TR, Ezzati M, Danaei G. Three public health interventions could save 94 million lives in 25 years global impact assessment analysis. Circulation. 2019;140:715–25. doi: 10.1161/CIRCULATIONAHA.118.038160. PubMed DOI PMC

World Health Organization. Saving lives, spending less: a strategic response to noncommunicable diseases. Geneva, Switzerland; 2018 (WHO/NMH/NVI/18.8). Licence: CC BY-NC-SA 3.0 IGO. Contract No.: WHO/NMH/NVI/18.8.

Nugent R. Benefits and costs of the non-communicable disease targets for the post-2015 development agenda. Copenhagen Consensus Center. 2015:I–II, 1–25.

Nilson EAF, Pearson-Stuttard J, Collins B, Guzman-Castillo M, Capewell S, O’Flaherty M, et al. Estimating the health and economic effects of the voluntary sodium reduction targets in Brazil: microsimulation analysis. BMC Medicine. 2021;19:225. doi: 10.1186/s12916-021-02099-x. PubMed DOI PMC

O’Donnell M, Mente A, Alderman MH, Brady AJB, Diaz R, Gupta R, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. Eur Heart J. 2020;41:3363–73. doi: 10.1093/eurheartj/ehaa586. PubMed DOI

Strazzullo P. Benefit assessment of dietary salt reduction: while the doctors study, should more people die? J Hypertens. 2011;29:829–31. doi: 10.1097/HJH.0b013e3283459568. PubMed DOI

Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) BMJ. 2007;334:885–92. doi: 10.1136/bmj.39147.604896.55. PubMed DOI PMC

O’Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612–23. doi: 10.1056/NEJMoa1311889. PubMed DOI

Mente A, O’Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392:496–506. doi: 10.1016/S0140-6736(18)31376-X. PubMed DOI

Cobb LK, Anderson CA, Elliott P, Hu FB, Liu K, Neaton JD, et al. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation. 2014;129:1173–86. doi: 10.1161/CIR.0000000000000015. PubMed DOI

Ji C, Sykes L, Paul C, Dary O, Legetic B, Campbell NRC, et al. Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake. Rev Panam Salud Publica. 2012;32:307–15. doi: 10.1590/S1020-49892012001000010. PubMed DOI

Cogswell ME, Wang CY, Chen TC, Pfeiffer CM, Elliott P, Gillespie CD, et al. Validity of predictive equations for 24-h urinary sodium excretion in adults aged 18-39 y. Am J Clin Nutr. 2013;98:1502–13. doi: 10.3945/ajcn.113.059436. PubMed DOI PMC

He FJ, Campbell NRC, Ma Y, MacGregor GA, Cogswell ME, Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. Int J Epidemiol. 2018;47:1784–95.. doi: 10.1093/ije/dyy114. PubMed DOI PMC

He FJ, Ma Y, Campbell NRC, MacGregor GA, Cogswell ME, Cook NR. Formulas to estimate dietary sodium intake from spot urine alter sodium-mortality relationship. Hypertension. 2019;74:572–80. doi: 10.1161/HYPERTENSIONAHA.119.13117. PubMed DOI

Naser AM, He FJ, Rahman M, Campbell NRC. Spot urine formulas to estimate 24-hour urinary sodium excretion alter the dietary sodium and blood pressure relationship. Hypertension. 2021;77:2127–37. doi: 10.1161/HYPERTENSIONAHA.120.16651. PubMed DOI PMC

Campbell NRC, He FJ, Cappuccio FP, MacGregor GA. Sources of controversy relating to dietary sodium. Issues and potential solutions. Cur Nutr Rep. 2021;10:188–99. doi: 10.1007/s13668-021-00357-1. PubMed DOI

Campbell NR, Appel LJ, Cappuccio FP, Correa-Rotter R, Hankey GJ, Lackland DT, et al. A call for quality research on salt intake and health: From the World Hypertension League and supporting organizations. J Clin Hypertens. 2014;16:469–71. doi: 10.1111/jch.12364. PubMed DOI PMC

Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, et al. The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 h) timed urine collections to assess dietary sodium intake. J Clin Hypertens. 2019;21:700–9. doi: 10.1111/jch.13551. PubMed DOI PMC

Campbell NR, Lackland DT, Niebylski ML, Nilsson PM. Is reducing dietary sodium controversial? Is it the conduct of studies with flawed research methods that is controversial? A perspective from the World Hypertension League Executive. J Clin Hypertens. 2015;17:85–6. doi: 10.1111/jch.12437. PubMed DOI PMC

Birukov A, Rakova N, Lerchl K, Engberink RH, Johannes B, Wabel P, et al. Ultra-long-term human salt balance studies reveal interrelations between sodium, potassium, and chloride intake and excretion. Am J Clin Nutr. 2016;104:49–57. doi: 10.3945/ajcn.116.132951. PubMed DOI PMC

McLean RM. Measuring population sodium intake: a review of methods. Nutrients. 2014;6:4651–62. doi: 10.3390/nu6114651. PubMed DOI PMC

Lucko AM, Doktorchik C, Woodward M, Cogswell M, Neal B, Rabi D, et al. Percentage of ingested sodium excreted in 24-hour urine collections: a systematic review and meta-analysis. J Clin Hypertens. 2018;20:1220–9. doi: 10.1111/jch.13353. PubMed DOI PMC

McLean R, Cameron C, Butcher E, Cook NR, Woodward M, Campbell NRC. Comparison of 24-hour urine and 24-hour diet recall for estimating dietary sodium intake in populations: a systematic review and meta-analysis. J Clin Hypertens. 2019;21:1753–62. doi: 10.1111/jch.13729. PubMed DOI PMC

McLean RM, Farmer VL, Nettleton A, Cameron CM, Cook NR, Campbell NRC. Assessment of dietary sodium intake using a food frequency questionnaire and 24-hour urinary sodium excretion: a systematic literature review. J Clin Hypertens. 2017;19:1214–30. doi: 10.1111/jch.13148. PubMed DOI PMC

McLean RM, Farmer VL, Nettleton A, Cameron CM, Cook NR, Woodward M, et al. Twenty-four-hour diet recall and diet records compared with 24-hour urinary excretion to predict an individual’s sodium consumption: a systematic review. J Clin Hypertens. 2018;20:1360–76. doi: 10.1111/jch.13391. PubMed DOI PMC

Olde Engberink RHG, van den Hoek TC, van Noordenne ND, van den Born BH, Peters-Sengers H, Vogt L. Use of a single baseline versus multiyear 24-hour urine collection for estimation of long-term sodium intake and associated cardiovascular and renal risk. Circulation. 2017;136:917–26. doi: 10.1161/CIRCULATIONAHA.117.029028. PubMed DOI

Wong MM, Arcand J, Leung AA, Thout SR, Campbell NR, Webster J. The Science of Salt: a regularly updated systematic review of salt and health outcomes (December 2015-March 2016) J Clin Hypertens. 2017;19:322–32. doi: 10.1111/jch.12970. PubMed DOI PMC

Webster J, Waqanivalu T, Arcand J, Trieu K, Cappuccio FP, Appel LJ, et al. Understanding the science that supports population-wide salt reduction programs. J Clin Hypertens. 2017;19:569–76. doi: 10.1111/jch.12994. PubMed DOI PMC

Johnson C, Raj TS, Trudeau L, Bacon SL, Padwal R, Webster J, et al. The Science of Salt: a systematic review of clinical salt studies 2013 to 2014. J Clin Hypertens. 2015;17:401–11. doi: 10.1111/jch.12529. PubMed DOI PMC

Johnson C, Raj TS, Trieu K, Arcand J, Wong MM, McLean R, et al. The Science of Salt: a systematic review of quality clinical salt outcome studies June 2014 to May 2015. J Clin Hypertens. 2016;18:832–9. doi: 10.1111/jch.12877. PubMed DOI PMC

Arcand J, Wong MMY, Santos JA, Leung AA, Trieu K, Thout SR, et al. More evidence that salt increases blood pressure and risk of kidney disease from the Science of Salt: a regularly updated systematic review of salt and health outcomes (April-July 2016) J Clin Hypertens. 2017;19:813–23. doi: 10.1111/jch.13049. PubMed DOI PMC

Arcand J, Wong MM, Trieu K, Leung AA, Campbell NR, Webster J, et al. The Science of Salt: a regularly updated systematic review of salt and health outcomes (June and July 2015) J Clin Hypertens. 2016;18:371–7. doi: 10.1111/jch.12762. PubMed DOI PMC

Arcand J, Webster J, Johnson C, Raj TS, Neal B, McLean R, et al. Announcing “Up to Date in the Science of Sodium”. J Clin Hypertens. 2016;18:85–8. doi: 10.1111/jch.12732. PubMed DOI PMC

Santos JA, Tekle D, Rosewarne E, Flexner N, Cobb L, Al-Jawaldeh A, et al. A systematic review of salt reduction initiatives around the world: a midterm evaluation of progress towards the 2025 global non-communicable diseases salt reduction target. Adv Nutr. 2021;12:1768–80. doi: 10.1093/advances/nmab008. PubMed DOI PMC

Hyseni L, Elliot-Green A, Lloyd-Williams F, Kypridemos C, O’Flaherty M, McGill R, et al. Systematic review of dietary salt reduction policies: evidence for an effectiveness hierarchy? PloS ONE. 2017;12:e0177535. doi: 10.1371/journal.pone.0177535. PubMed DOI PMC

Ide N, Ajenikoko A, Steele L, Cohn J, J. Curtis C, Frieden TR, et al. Priority actions to advance population sodium reduction. Nutrients. 2020;12:2543. doi: 10.3390/nu12092543. PubMed DOI PMC

World Health Organization. WHO global sodium benchmarks for different food categories. Geneva 2021.

Campbell N, Legowski B, Legetic B, Ferrante D, Nilson E, Campbell C, et al. Targets and timelines for reducing salt in processed food in the Americas. J Clin Hypertens. 2014;16:619–23. doi: 10.1111/jch.12379. PubMed DOI PMC

Campbell N, Legowski B, Legetic B, Nilson E, L’Abbe M. Inaugural maximum values for sodium in processed food products in the Americas. J Clin Hypertens. 2015;17:611–3. doi: 10.1111/jch.12553. PubMed DOI PMC

Pan American Health Organization. Updated PAHO regional sodium reduction targets. Washington DC. 2021. p. 1–19.

Pan American Health Organization. Salt-Smart Americas: a guide for country-level action. Washington, DC: Pan American Health Organization; 2013. Report No.: 978-75-31769-3.

World Health Organization Regional Office for Europe. Accelerating salt reduction in Europe. 2020.

Jaenke R, Barzi F, McMahon E, Webster J, Brimblecombe J. Consumer acceptance of reformulated food products: a systematic review and meta-analysis of salt-reduced foods. Critical Rev Food Sci Nutr. 2017;57:3357–72.. doi: 10.1080/10408398.2015.1118009. PubMed DOI

Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49:59–75. doi: 10.1016/j.pcad.2006.07.001. PubMed DOI

He FJ, Pombo-Rodrigues S, MacGregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open. 2014;4:e004549. doi: 10.1136/bmjopen-2013-004549. PubMed DOI PMC

Uechi K, Sugimoto M, Kobayashi S, Sasaki S. Urine 24-Hour sodium excretion decreased between 1953 and 2014 in Japan, but estimated intake still exceeds the WHO recommendation. J Nutr. 2017;147:390–7. PubMed

Chalmers J, Arima H, Hata J. Cost-effective reduction in stroke: lessons from the Japanese hypertension detection and control program. J Hypertens. 2012;30:1706–7. doi: 10.1097/HJH.0b013e32835789ff. PubMed DOI

Nakagawa H, Miura K. Salt reduction in a population for the prevention of hypertension. Environ Health and Prev Med. 2004;9:123. doi: 10.1007/BF02898090. PubMed DOI PMC

Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III - Analysis of data from trials of salt reduction. BMJ. 1991;302:819–24. doi: 10.1136/bmj.302.6780.819. PubMed DOI PMC

World Health Organization. SHAKE the salt habit. The SHAKE Technical Package for Salt Reduction. Geneva: World Health Organization. 2016. p. 1–60.

Theobald S, Brandes N, Gyapong M, El-Saharty S, Proctor E, Diaz T, et al. Implementation research: new imperatives and opportunities in global health. Lancet. 2018;392:2214–28.. doi: 10.1016/S0140-6736(18)32205-0. PubMed DOI

Jacobson MF, Havas S, McCarter R. Changes in sodium levels in processed and restaurant foods, 2005 to 2001. JAMA Intern Med. 2013;173:1285–91. doi: 10.1001/jamainternmed.2013.6154. PubMed DOI

Cobiac LJ, Vos T, Veerman JL. Cost-effectiveness of interventions to reduce dietary salt intake. Heart. 2010;96:1920–5. doi: 10.1136/hrt.2010.199240. PubMed DOI

Khalig M, Sommariva S, Bardfield L, Blanco-Metzler A, Benítez GSL, Gomes A, et al. Salt reduction in Latin America. A regional social marketing & communication plan. Project - IDRC 108167 Scaling up and evaluating salt reduction policies and programs in Latin American countries. 2016–2020. In: (INCIENSA) CRIoRaTiHaN, editor. Tres Ríos, Costa Rica: INCIENSA; 2019.

Xu A, Ma J, Guo X, Wang L, Wu J, Zhang J, et al. Association of a province-wide intervention with salt intake and hypertension in Shandong Province, China, 2011–2016. JAMA Intern Med. 2020;180:877–86. doi: 10.1001/jamainternmed.2020.0904. PubMed DOI PMC

Trieu K, McMahon E, Santos JA, Bauman A, Jolly KA, Bolam B, et al. Review of behaviour change interventions to reduce population salt intake. Int J Behav Nutr Phys Act. 2017;14:17. doi: 10.1186/s12966-017-0467-1. PubMed DOI PMC

Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi: 10.1186/1748-5908-6-42. PubMed DOI PMC

Bardfield L Applying a social marketing framework to salt reduction In: fhi360, editor. Washington DC: fhi360; 2012.

Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021;385:1067–77.. doi: 10.1056/NEJMoa2105675. PubMed DOI

Greer RC, Marklund M, Anderson CAM, Cobb LK, Dalcin AT, Henry M, et al. Potassium-enriched salt substitutes as a means to lower blood pressure. Hypertension. 2020;75:266–74.. doi: 10.1161/HYPERTENSIONAHA.119.13241. PubMed DOI

Hernandez AV, Emonds EE, Chen BA, Zavala-Loayza AJ, Thota P, Pasupuleti V, et al. Effect of low-sodium salt substitutes on blood pressure, detected hypertension, stroke and mortality. Heart. 2019;105:653–960.. PubMed

Chang HY, Hu YW, Yue CS, Wen YW, Yeh WT, Hsu LS, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr. 2006;83:1289–96. doi: 10.1093/ajcn/83.6.1289. PubMed DOI

Bernabe-Ortiz A, Sal y Rosas VG, Ponce-Lucero V, Cárdenas MK, Carrillo-Larco RM, Diez-Canseco F, et al. Effect of salt substitution on community-wide blood pressure and hypertension incidence. Nat Med. 2020;26:374–8. doi: 10.1038/s41591-020-0754-2. PubMed DOI PMC

Marklund M, Singh G, Greer R, Cudhea F, Matsushita K, Micha R, et al. Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study. BMJ. 2020;369:m824. doi: 10.1136/bmj.m824. PubMed DOI PMC

Li N, Yan LL, Niu W, Yao C, Feng X, Zhang J, et al. The effects of a community-based sodium reduction program in rural China - A cluster-randomized trial. PloS ONE. 2016;11:e0166620–e. doi: 10.1371/journal.pone.0166620. PubMed DOI PMC

Farrand C, MacGregor G, Campbell NR, Webster J. Potential use of salt substitutes to reduce blood pressure. J Clin Hypertens. 2019;21:350–4. doi: 10.1111/jch.13482. PubMed DOI PMC

Campbell N, Dary O, Cappuccio FP, Neufeld LM, Harding KB, Zimmermann MB. Collaboration to optimize dietary intakes of salt and iodine: a critical but overlooked public health issue. Bull World Health Organ. 2012;90:73–4. doi: 10.2471/BLT.11.092080. PubMed DOI PMC

Campbell NRC, Dary O, Cappuccio FP, Neufeld LM, Harding KB, Zimmerman MB. Need for coordinated programs to improve global health by optimizing salt and iodine intake. Special Report. Rev Panam Salud Publica. 2012;32:281–6. doi: 10.1590/S1020-49892012001000006. PubMed DOI

Webster J, Santos JA, Hogendorf M, Trieu K, Rosewarne E, McKenzie B, et al. Implementing effective salt reduction programs and policies in low- and middle-income countries: learning from retrospective policy analysis in Argentina, Mongolia, South Africa and Vietnam. Public Health Nutr. 2021 doi: 10.1017/S136898002100344X. PubMed DOI PMC

Santos JA, McKenzie B, Rosewarne E, Hogendorf M, Trieu K, Woodward M, et al. Strengthening knowledge to practice on effective salt reduction interventions in low- and middle-income countries. Curr Nutr Rep. 2021;10:211–25.. doi: 10.1007/s13668-021-00365-1. PubMed DOI

Campbell NR, Lackland DT, Niebylski ML, Orias M, Redburn KA, Nilsson PM, et al. 2016 dietary salt fact sheet and call to action: The World Hypertension League, International Society of Hypertension, and the International Council of Cardiovascular Prevention and Rehabilitation. J Clin Hypertens. 2016;18:1082–4. doi: 10.1111/jch.12894. PubMed DOI PMC

National Institute of Nutrition, Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India,. Nutrient requirements of Indians. Hyderabad, India: Indian Council of Medical Research; 2020. p. 1–321.

Ministry of Health. Towards a healthy Russia. Healthy nutrition: plan of action to develop regional programmes in the Russian Federation. 2000.

Brasil. Ministério da Saúde. Estratégias para o cuidado da pessoa com doença crônica: hipertensão arterial sistêmica / Strategies for the care of the person with chronic disease: hypertension. In: Departamento de Atenção Básica, editor. 2014.

Ministry of Health. Strategic plan for the prevention and control of non-communicable diseases 2013–17. South Africa: Minstry of Health; 2013.

Federal Ministry of Health. National multi-sectoral action plan for the prevention and control of non-communicable diseases (2019–2025). Nigeria, 2019.

Genovesi S, Giussani M, Orlando A, Orgiu F, Parati G. Salt and sugar: two enemies of healthy blood pressure in children. Nutrients. 2021;13:697. doi: 10.3390/nu13020697. PubMed DOI PMC